Mahmoud M. Iravani
Neurodegenerative Disease Research Centre
Institute of Pharmaceutical Sciences
School of Biomedical Sciences
King's College
UK
Name/email consistency: high
- Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation. Iravani, M.M., Jenner, P. J. Neural. Transm (2011)
- In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates, the selective 5-hydroxytryptamine 1a agonist (R)-(+)-8-OHDPAT inhibits levodopa-induced dyskinesia but only with\ increased motor disability. Iravani, M.M., Tayarani-Binazir, K., Chu, W.B., Jackson, M.J., Jenner, P. J. Pharmacol. Exp. Ther. (2006)
- Direct effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin or dopamine release and uptake in the caudate putamen, nucleus accumbens, substantia nigra pars reticulata, and the dorsal raphé nucleus slices. Iravani, M.M., Asari, D., Patel, J., Wieczorek, W.J., Kruk, Z.L. Synapse (2000)
- MK-801 interaction with the 5-HT transporter: a real-time study in brain slices using fast cyclic voltammetry. Iravani, M.M., Muscat, R., Kruk, Z.L. Synapse (1999)
- The presence and the effects of neuropeptide Y in rat anococcygeus muscle. Iravani, M.M., Aboo Zar, M. Eur. J. Pharmacol. (1997)